NCT06422130

Brief Summary

With the implementation of China's two-child policy and a marked increase in adverse pregnancy outcomes, leveraging electronic health records (EHR) to enhance maternal and child healthcare and outcomes in China has emerged as a novel strategy to tackle this pivotal demographic and health challenge. Given the mature construction of the information platform and the well-established maternal and child health service system in Ningbo, this study utilized the Ningbo Maternal and Child Health Electronic Monitoring Information Management System and the Ningbo Regional Health Information Platform to conduct the Ningbo maternity-child linked database study (MATCHLESS), which involved over 300,000 mother-child pairs in China. MATCHLESS not only allows for longitudinal follow-up of pregnant women and their offspring but also expands its scope from prenatal exposure to long-term outcomes through data linkage. The longitudinal scope of MATCHLESS facilitates the elucidation of the relationship and etiological significance of early-life exposures and adverse pregnancy outcomes. It also permits the exploration of the health trajectory of women and children over their life-course. During the past 5 years (October 2016 to December 2021), a substantial amount of maternal and child health data has been recorded in MATCHLESS, including socio-demographics, health care services and medications, as well as clinical outcome events. Additionally, it contains longitudinal measurements on risk factors for adverse pregnancy outcomes, which provides a robust foundation for future real-world studies of dynamic predictive models. This study was approved by the Ethics Review Committee of the Ningbo University Health Science Center. Considering the safety, privacy, and confidentiality concerns surrounding the storage and processing of personal EHR data, the responsibility for data storage and management is undertaken by the Health Commission of Ningbo. Researchers are required to submit applications to the local health department, and all studies undergo ethical review and research registration procedures to access EHR data for health research purposes.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
325,596

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Oct 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress94%
Oct 2016Dec 2026

Study Start

First participant enrolled

October 1, 2016

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
2.4 years until next milestone

First Submitted

Initial submission to the registry

May 8, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 20, 2024

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

May 25, 2025

Status Verified

May 1, 2025

Enrollment Period

5.3 years

First QC Date

May 8, 2024

Last Update Submit

May 20, 2025

Conditions

Keywords

Population-based healthcare databaseLongitudinal studyAmbispective CohortPregnant women and offspring

Outcome Measures

Primary Outcomes (13)

  • Incidence of preterm birth

    Regular contractions accompanied by cervical change at less than 37 weeks' gestation. Or, the following diagnose in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : O60.

    Up to 42 weeks

  • Incidence of pre-eclampsia

    New onset hypertension (\>140 mm Hg systolic or \>90 mm Hg diastolic) after 20 weeks of pregnancy and the coexistence of one or both of the following new-onset conditions: proteinuria (urine protein:creatinine ratio ≥30 mg/mmol, or albumin: creatinine ratio ≥8 mg/mmol, or ≥1 g/L \[2+\] on dipstick testing), other maternal organ dysfunction, including features such as renal or liver involvement, neurological or haematological complications, or uteroplacental dysfunction (such as fetal growth restriction, abnormal umbilical artery Doppler waveform analysis, or stillbirth). Or, the following diagnose in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : O14.

    Up to 42 weeks

  • Incidence of eclampsia

    The occurrence of new-onset, generalized, tonic-clonic seizures or coma in a patient with preeclampsia or gestational hypertension. Or, the following diagnose in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : O15.

    Up to 42 weeks

  • Incidence of gestational diabetes mellitus

    Impaired Glucose Tolerance (IGT) with onset or first recognition during pregnancy. Or, the following diagnose in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : O24.4.

    Up to 42 weeks

  • Incidence of low birth weight

    Weight at birth of \< 2500 g. Or, at least one of the following diagnoses in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : P07.0, P07.1.

    Up to 42 weeks

  • Incidence of small for gestational age

    Less than the tenth birth weight centile using INTERGROWTH-21st. Or, the following diagnose in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : P05.

    Up to 42 weeks

  • Incidence of autism

    The following diagnose in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : F84.

    Up to 10 years

  • Incidence of birth defects

    Birth defects such as congenital malformations of the nervous system, congenital malformations of eye, ear, face and neck, congenital malformations of the circulatory system, congenital malformations of the respiratory system, or other birth defects. Or, at least one of the following diagnoses in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : Q00-Q99.

    Up to 10 years

  • Incidence of postpartum hemorrhage

    Blood loss exceeding 500 mL following vaginal birth and 1000 mL following cesarean. Or, the following diagnose in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : O72.

    Within 24 hours after delivery

  • Incidence of stillbirth

    Death of a fetus that has reached a birth weight of 500 g, or if birth weight is unavailable, gestational age of 22 weeks or crown-to-heel length of 25 cm. Or, at least one of the following diagnoses in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : Z37.1, Z37.3, Z37.4, Z37.7.

    Up to 42 weeks

  • Incidence of ruptured uterus

    Uterine rupture is confirmed by laparotomy. Or, at least one of the following diagnoses in the electronic health records according to the International Classification of Diseases 10th Revision (ICD-10) : O71.0, O71.1, O34.5, O62.4.

    Up to 42 weeks

  • Incidence of maternal death

    Death of women while pregnant or within 42 days of termination of pregnancy irrespective of the site and size of pregnancy but related to or aggravated by the pregnancy or its management but not from accidental or incidental causes.

    Up to 52 weeks

  • Incidence of neonatal death

    Deaths among live births during the first 28 completed days of life.

    Within 28 days after delivery

Study Arms (1)

Pregnant women and their offspring

Other: Pregnant women and their offspring without intervention

Interventions

Pregnant women and their offspring with those exposures of interest determined in specific research based on the database

Pregnant women and their offspring

Eligibility Criteria

Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll pregnant women and their offspring registered at the Ningbo maternal and child health electronic monitoring information management system were enrolled.
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Pregnant women and their offspring who registered at the Ningbo maternal and child health electronic monitoring information management system.

You may qualify if:

  • Pregnant women and their offspring who registered at the Ningbo maternal and child health electronic monitoring information management system.

You may not qualify if:

  • None.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ningbo University

Ningbo, Zhejiang, 315000, China

Location

Related Publications (1)

  • Li N, Ye H, Zhu H, Liang M, Wang K, Zhao Y, Liu L. Association of prenatal exposure to air pollution with autism spectrum disorder: A population-based retrospective cohort study in China. Environ Res. 2026 Feb 15;291:123612. doi: 10.1016/j.envres.2025.123612. Epub 2025 Dec 22.

MeSH Terms

Interventions

Methods

Intervention Hierarchy (Ancestors)

Investigative Techniques

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
10 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 8, 2024

First Posted

May 20, 2024

Study Start

October 1, 2016

Primary Completion

December 31, 2021

Study Completion (Estimated)

December 31, 2026

Last Updated

May 25, 2025

Record last verified: 2025-05

Locations